CD79A and B-cell chronic lymphocytic leukemia: It prevents in vitro proliferation and IgA production of APRIL-reactive B cells, and effectively impairs the chronic lymphocytic leukemia (CLL)-like phenotype of aging APRIL transgenic mice.